Radiofrequency targeted vertebral augmentation (also written as RF-TVA) is a form of kyphoplasty that uses radiofrequency heat to control the viscosity of polymethylmethacrylate cement and deliver it into the vertebral body to treat vertebral compression fractures.[1]

Procedure

Radiofrequency targeted vertebral augmentation is a minimally invasive procedure designed to preserve good bone while performing vertebral augmentation (sometimes referred to as kyphoplasty).[2] With traditional kyphoplasty, a balloon is used to create a space within the cancellous bone and then cement is injected into the space. The RF-TVA procedure is different in that a physician directs a small navigational canula into the vertebra and creates a small pathways for the cement as opposed to using a balloon. This process preserves more of the healthy canncellous bone.[1][3] The pathways are then filled with ultra-high viscosity bone cement which then permeates into the surrounding bone, stabilizing the fracture[4] and restoring vertebral height.[1] As of 2014, the system has been used to treat more than 15,000 spinal fractures worldwide.

History

RF-TVA was first developed by DFINE, Inc., a medical device company based in San Jose, California.[5] Its product, the StabiliT Vertebral Augmentation System received 510(k) clearance from the United States Food and Drug Administration in 2008 and is CE marked for commercial sale in Europe.

See also

References

  1. 1 2 3 Dalton, BE; AC Kohm; LE Miller; JE Block; RD Poser (19 November 2012). "Radiogrequency-targeted vertebral augmentation versus traditional balloon kyphoplasty". Clinical Interventions in Aging. 7: 525–531. doi:10.2147/CIA.S37025. PMC 3508556. PMID 23204845.
  2. ↑ Moser, Franklin G.; Marcel M Maya; Laura Blaszkiewicz; Andrea Scicli; Larry E Miller; Jon E. Block (20 October 2013). "Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture". Journal of Osteoporosis. 2013: 791397. doi:10.1155/2013/791397. PMC 3817678. PMID 24228187.
  3. ↑ Robertson, Scott C. (2011). "Percutaneous Vertebral Augmentation: StabilitiT™ A New Delivery System for Vertebral Fractures". Advances in Minimally Invasive Surgery and Therapy for Spine and Nerves. Acta Neurochirurgica Supplementum. Vol. 108. pp. 191–195. doi:10.1007/978-3-211-99370-5_29. ISBN 978-3-211-99369-9. PMID 21107958.
  4. ↑ Erdem, Eren; Sertack Akdol; Adewumi Amole; Katy Fryar; Robert W. Eberle (1 July 2013). "Radiofrequency-Targeted Vertebral Augmentation for the Treatment of Vertebral Compression Fractures as a Result of Multiple Myeloma". Spine Journal. 38 (15): 1275–1281. doi:10.1097/BRS.0b013e3182959695. PMID 23591655. S2CID 205519573.
  5. ↑ Chandler, Michele (15 August 2010). "DFine Inc. cements future in vertebrae surgical market". San Jose Business Journal. Retrieved 5 May 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.